Concepedia

Martin Johnson

MJ

Statistics

Publications

24

Citations

1.9K

H-Index

19

Active since

1999

Affiliations

UCB Pharma (United States)(Current)

University of Sheffield

University College London

The University of Melbourne

UCB Pharma (Germany)

Martin Johnson is an author at UCB Pharma (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Publications per year

1999–2022

24

Publications

24

Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial

Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil et al. · Epilepsia · 2013 · 251 citations · Full text

, , +13

Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trial

Philippe Ryvlin, Konrad J. Werhahn, Barbara Błaszczyk et al. · Epilepsia · 2013 · 230 citations · Full text

, , +14

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial

Solomon Tesfaye, Gordon Sloan, Jennifer Petrie et al. · The Lancet · 2022 · 191 citations · Full text

, , +17

Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase <scp>III</scp>, double‐blind, randomized, placebo‐controlled, flexible‐dose trial

Patrick Kwan, Eugen Trinka, Wim Van Paesschen et al. · Epilepsia · 2013 · 161 citations

, , +16

Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial‐onset seizures: A phase IIb, randomized, controlled trial

Wim Van Paesschen, Édouard Hirsch, Martin Johnson et al. · Epilepsia · 2012 · 140 citations

, , +16

1–5 of 24